Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genome, Human | 19 | 2017 | 4420 | 0.600 |
Why?
|
Brain Neoplasms | 11 | 2022 | 8863 | 0.580 |
Why?
|
Meningeal Carcinomatosis | 3 | 2021 | 65 | 0.560 |
Why?
|
Mutation | 47 | 2021 | 29786 | 0.560 |
Why?
|
Drug Resistance, Neoplasm | 12 | 2020 | 5172 | 0.520 |
Why?
|
Genome | 2 | 2022 | 1808 | 0.500 |
Why?
|
Meningeal Neoplasms | 5 | 2021 | 1241 | 0.470 |
Why?
|
Neoplasms | 16 | 2022 | 21683 | 0.450 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 5 | 2019 | 890 | 0.410 |
Why?
|
Gene Expression Profiling | 13 | 2019 | 9438 | 0.400 |
Why?
|
DNA Mutational Analysis | 10 | 2017 | 4186 | 0.370 |
Why?
|
Melanoma | 5 | 2022 | 5510 | 0.370 |
Why?
|
TOR Serine-Threonine Kinases | 6 | 2019 | 2109 | 0.340 |
Why?
|
Genetic Techniques | 1 | 2012 | 435 | 0.340 |
Why?
|
DNA Copy Number Variations | 10 | 2022 | 1941 | 0.330 |
Why?
|
Gene Expression Regulation, Neoplastic | 15 | 2021 | 8428 | 0.330 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2013 | 3920 | 0.320 |
Why?
|
Genomics | 12 | 2022 | 5720 | 0.310 |
Why?
|
Chromosomal Instability | 2 | 2007 | 184 | 0.280 |
Why?
|
Tumor Suppressor Protein p53 | 11 | 2021 | 2948 | 0.270 |
Why?
|
Software | 5 | 2022 | 4443 | 0.260 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2019 | 2938 | 0.260 |
Why?
|
Genetic Heterogeneity | 5 | 2016 | 733 | 0.260 |
Why?
|
Leiomyosarcoma | 2 | 2019 | 477 | 0.230 |
Why?
|
Tumor Microenvironment | 5 | 2022 | 3586 | 0.230 |
Why?
|
Cell Physiological Phenomena | 1 | 2004 | 154 | 0.220 |
Why?
|
Rhabdoid Tumor | 2 | 2017 | 212 | 0.220 |
Why?
|
DNA, Neoplasm | 5 | 2015 | 1758 | 0.210 |
Why?
|
Barrett Esophagus | 2 | 2018 | 494 | 0.210 |
Why?
|
Neoplasm Metastasis | 7 | 2020 | 4851 | 0.210 |
Why?
|
Pyrimidines | 3 | 2019 | 2942 | 0.210 |
Why?
|
Lung Neoplasms | 9 | 2020 | 13102 | 0.210 |
Why?
|
Sequence Analysis, DNA | 10 | 2015 | 4803 | 0.210 |
Why?
|
DNA, Complementary | 1 | 2005 | 2050 | 0.200 |
Why?
|
Esophageal Neoplasms | 3 | 2018 | 1583 | 0.200 |
Why?
|
Gene Dosage | 4 | 2019 | 1252 | 0.190 |
Why?
|
Point Mutation | 4 | 2015 | 1623 | 0.180 |
Why?
|
Tumor Suppressor Proteins | 3 | 2017 | 2849 | 0.180 |
Why?
|
Cell Line, Tumor | 15 | 2020 | 16689 | 0.180 |
Why?
|
Evolution, Molecular | 4 | 2016 | 1940 | 0.180 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2022 | 3597 | 0.180 |
Why?
|
Ploidies | 4 | 2013 | 281 | 0.180 |
Why?
|
Breast Neoplasms | 8 | 2020 | 20822 | 0.170 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2016 | 1596 | 0.170 |
Why?
|
Radiation Tolerance | 2 | 2019 | 486 | 0.170 |
Why?
|
PTEN Phosphohydrolase | 5 | 2017 | 1142 | 0.170 |
Why?
|
Meningioma | 2 | 2018 | 1209 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 322 | 0.160 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2014 | 388 | 0.160 |
Why?
|
Cerebellar Neoplasms | 2 | 2014 | 587 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2019 | 705 | 0.160 |
Why?
|
Ovarian Neoplasms | 4 | 2020 | 4838 | 0.160 |
Why?
|
NF-E2-Related Factor 2 | 3 | 2015 | 377 | 0.160 |
Why?
|
DNA | 1 | 2012 | 7301 | 0.160 |
Why?
|
Telomerase | 2 | 2020 | 730 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 6 | 2019 | 5535 | 0.150 |
Why?
|
Oxazines | 1 | 2019 | 298 | 0.150 |
Why?
|
Humans | 81 | 2022 | 744343 | 0.150 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2016 | 4034 | 0.150 |
Why?
|
Dystrophin | 1 | 2018 | 285 | 0.150 |
Why?
|
Disease Progression | 8 | 2018 | 13284 | 0.140 |
Why?
|
Algorithms | 9 | 2022 | 13881 | 0.140 |
Why?
|
Chromosomes, Human | 2 | 2016 | 457 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2015 | 489 | 0.140 |
Why?
|
Gene Expression Regulation | 2 | 2005 | 12072 | 0.140 |
Why?
|
Liposarcoma | 1 | 2019 | 333 | 0.140 |
Why?
|
Aneuploidy | 2 | 2012 | 530 | 0.140 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 627 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 11524 | 0.140 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2016 | 2043 | 0.130 |
Why?
|
Adenocarcinoma | 5 | 2018 | 6364 | 0.130 |
Why?
|
Computational Biology | 3 | 2014 | 3521 | 0.130 |
Why?
|
RNA | 2 | 2005 | 2749 | 0.130 |
Why?
|
Endometrial Hyperplasia | 1 | 2016 | 97 | 0.130 |
Why?
|
Gene Expression | 4 | 2015 | 7799 | 0.130 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 783 | 0.130 |
Why?
|
Janus Kinase 3 | 1 | 2015 | 78 | 0.130 |
Why?
|
Signal Transduction | 10 | 2019 | 23403 | 0.130 |
Why?
|
Mutagenesis | 3 | 2013 | 1266 | 0.130 |
Why?
|
Neoplasms, Squamous Cell | 2 | 2013 | 96 | 0.120 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2019 | 571 | 0.120 |
Why?
|
Abdominal Neoplasms | 1 | 2016 | 292 | 0.120 |
Why?
|
Uveal Neoplasms | 1 | 2017 | 310 | 0.120 |
Why?
|
Hemangioblastoma | 1 | 2014 | 70 | 0.120 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 254 | 0.120 |
Why?
|
Endometrial Neoplasms | 2 | 2016 | 1353 | 0.120 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2017 | 449 | 0.120 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 192 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2019 | 2942 | 0.110 |
Why?
|
Tongue Neoplasms | 1 | 2015 | 180 | 0.110 |
Why?
|
Polyploidy | 1 | 2013 | 114 | 0.110 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 290 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2013 | 191 | 0.110 |
Why?
|
Carcinoma | 2 | 2017 | 2375 | 0.110 |
Why?
|
Models, Biological | 2 | 2012 | 9583 | 0.110 |
Why?
|
Cyclin E | 1 | 2013 | 172 | 0.110 |
Why?
|
Anus Neoplasms | 1 | 2016 | 332 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 323 | 0.110 |
Why?
|
Genes, p53 | 1 | 2015 | 755 | 0.110 |
Why?
|
Oncogene Proteins | 2 | 2015 | 749 | 0.110 |
Why?
|
Gene Amplification | 2 | 2015 | 1063 | 0.110 |
Why?
|
Piperazines | 2 | 2021 | 2488 | 0.110 |
Why?
|
Skin Neoplasms | 3 | 2020 | 5686 | 0.110 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 730 | 0.110 |
Why?
|
Drug Synergism | 1 | 2016 | 1792 | 0.110 |
Why?
|
Chromosome Breakage | 1 | 2012 | 173 | 0.100 |
Why?
|
Bone Neoplasms | 2 | 2014 | 2529 | 0.100 |
Why?
|
Spinal Cord Neoplasms | 1 | 2014 | 281 | 0.100 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2013 | 199 | 0.100 |
Why?
|
Mediator Complex | 1 | 2012 | 109 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2016 | 9239 | 0.100 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2012 | 170 | 0.100 |
Why?
|
Antineoplastic Agents | 7 | 2019 | 13695 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2015 | 578 | 0.100 |
Why?
|
Retinoblastoma Protein | 3 | 2013 | 704 | 0.100 |
Why?
|
Case-Control Studies | 5 | 2022 | 21746 | 0.100 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 501 | 0.100 |
Why?
|
Urinary Bladder | 1 | 2017 | 1172 | 0.100 |
Why?
|
Cytidine Deaminase | 1 | 2013 | 252 | 0.100 |
Why?
|
Female | 37 | 2021 | 380194 | 0.100 |
Why?
|
Intestinal Neoplasms | 1 | 2013 | 319 | 0.100 |
Why?
|
Precancerous Conditions | 1 | 2018 | 975 | 0.100 |
Why?
|
Cluster Analysis | 4 | 2015 | 2715 | 0.100 |
Why?
|
Neurofibromin 1 | 1 | 2012 | 196 | 0.090 |
Why?
|
Neuroendocrine Tumors | 2 | 2013 | 594 | 0.090 |
Why?
|
Stathmin | 1 | 2010 | 71 | 0.090 |
Why?
|
Central Nervous System Neoplasms | 1 | 2019 | 895 | 0.090 |
Why?
|
Recombination, Genetic | 2 | 2012 | 1586 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2751 | 0.090 |
Why?
|
Sunlight | 1 | 2012 | 325 | 0.090 |
Why?
|
Oncogenes | 2 | 2013 | 1265 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 783 | 0.090 |
Why?
|
Biotechnology | 1 | 2012 | 281 | 0.090 |
Why?
|
Rectal Neoplasms | 1 | 2019 | 1206 | 0.090 |
Why?
|
Biological Specimen Banks | 1 | 2015 | 711 | 0.090 |
Why?
|
Protein Biosynthesis | 1 | 2017 | 2126 | 0.090 |
Why?
|
Cell Separation | 2 | 2013 | 1751 | 0.090 |
Why?
|
Male | 31 | 2021 | 350118 | 0.090 |
Why?
|
Head and Neck Neoplasms | 2 | 2015 | 2734 | 0.090 |
Why?
|
Chromosome Aberrations | 2 | 2013 | 1813 | 0.080 |
Why?
|
Organoids | 1 | 2015 | 701 | 0.080 |
Why?
|
Osteosarcoma | 1 | 2014 | 881 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 1378 | 0.080 |
Why?
|
Cell Cycle | 3 | 2019 | 2967 | 0.080 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2012 | 671 | 0.080 |
Why?
|
Pyrazoles | 2 | 2016 | 1972 | 0.080 |
Why?
|
Middle Aged | 23 | 2021 | 213383 | 0.080 |
Why?
|
Phylogeny | 3 | 2016 | 2803 | 0.080 |
Why?
|
Receptor, Notch1 | 1 | 2011 | 502 | 0.080 |
Why?
|
RNA, Neoplasm | 2 | 2015 | 769 | 0.080 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2012 | 581 | 0.080 |
Why?
|
Lysosomes | 1 | 2013 | 893 | 0.080 |
Why?
|
Chromosome Breakpoints | 3 | 2012 | 98 | 0.080 |
Why?
|
Nausea | 2 | 2021 | 673 | 0.080 |
Why?
|
Pituitary Neoplasms | 1 | 2016 | 1345 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1513 | 0.080 |
Why?
|
Homozygote | 1 | 2012 | 1785 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2018 | 1634 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1564 | 0.070 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2012 | 736 | 0.070 |
Why?
|
Amino Acids | 1 | 2013 | 1736 | 0.070 |
Why?
|
Medulloblastoma | 1 | 2012 | 683 | 0.070 |
Why?
|
Microtubule-Associated Proteins | 1 | 2012 | 1086 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 2455 | 0.070 |
Why?
|
Genes, myc | 2 | 2020 | 399 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 6 | 2019 | 17446 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1420 | 0.070 |
Why?
|
HEK293 Cells | 4 | 2020 | 4204 | 0.070 |
Why?
|
Databases, Genetic | 2 | 2014 | 1783 | 0.070 |
Why?
|
Aged, 80 and over | 10 | 2021 | 57776 | 0.070 |
Why?
|
DNA-Binding Proteins | 5 | 2015 | 9648 | 0.070 |
Why?
|
Genetic Variation | 2 | 2018 | 6544 | 0.070 |
Why?
|
Aged | 16 | 2021 | 163280 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2012 | 2503 | 0.060 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18029 | 0.060 |
Why?
|
raf Kinases | 2 | 2016 | 122 | 0.060 |
Why?
|
Prostatic Neoplasms | 3 | 2013 | 11124 | 0.060 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2017 | 2245 | 0.060 |
Why?
|
Neuroblastoma | 1 | 2013 | 1226 | 0.060 |
Why?
|
Germ-Line Mutation | 3 | 2018 | 1788 | 0.060 |
Why?
|
Leukocytes | 1 | 2013 | 2043 | 0.060 |
Why?
|
Adult | 17 | 2021 | 214055 | 0.060 |
Why?
|
DNA Probes | 1 | 2005 | 560 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2020 | 1723 | 0.060 |
Why?
|
Apoptosis | 5 | 2019 | 9727 | 0.060 |
Why?
|
Core Binding Factor beta Subunit | 2 | 2013 | 45 | 0.060 |
Why?
|
Mice, Nude | 2 | 2020 | 3689 | 0.060 |
Why?
|
Survival Analysis | 3 | 2021 | 10252 | 0.060 |
Why?
|
E1A-Associated p300 Protein | 2 | 2013 | 131 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2013 | 5021 | 0.050 |
Why?
|
Gene Regulatory Networks | 3 | 2018 | 1708 | 0.050 |
Why?
|
Oximes | 2 | 2013 | 311 | 0.050 |
Why?
|
Transcription Factors | 4 | 2020 | 12208 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2020 | 6895 | 0.050 |
Why?
|
Embryonic Development | 1 | 2007 | 711 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 2020 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5974 | 0.050 |
Why?
|
Biopsy | 3 | 2019 | 6756 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2014 | 2282 | 0.050 |
Why?
|
Anorexia | 1 | 2021 | 161 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25043 | 0.050 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2021 | 92 | 0.050 |
Why?
|
Alleles | 1 | 2012 | 6933 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 1692 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5256 | 0.050 |
Why?
|
Glioma | 1 | 2015 | 3401 | 0.050 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2020 | 103 | 0.040 |
Why?
|
Hepatitis | 1 | 2021 | 227 | 0.040 |
Why?
|
MAP Kinase Signaling System | 2 | 2018 | 1526 | 0.040 |
Why?
|
Computer Graphics | 1 | 2002 | 361 | 0.040 |
Why?
|
Molecular Targeted Therapy | 3 | 2015 | 2727 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2016 | 19905 | 0.040 |
Why?
|
Cohort Studies | 5 | 2018 | 40561 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 20 | 0.040 |
Why?
|
Bone Marrow Diseases | 1 | 2021 | 231 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2019 | 11366 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2012 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4262 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2013 | 14722 | 0.040 |
Why?
|
Mice | 8 | 2020 | 81183 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2020 | 290 | 0.040 |
Why?
|
Colon | 1 | 2007 | 1772 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2020 | 323 | 0.040 |
Why?
|
Gene Rearrangement | 2 | 2014 | 1179 | 0.040 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2012 | 670 | 0.040 |
Why?
|
Genome-Wide Association Study | 5 | 2015 | 12261 | 0.040 |
Why?
|
Proteins | 1 | 2013 | 6103 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2019 | 10481 | 0.040 |
Why?
|
Eukaryotic Initiation Factor-1 | 1 | 2017 | 33 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 538 | 0.040 |
Why?
|
Ribosomes | 1 | 2021 | 500 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2017 | 3616 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2020 | 629 | 0.040 |
Why?
|
Imidazoles | 2 | 2013 | 1206 | 0.040 |
Why?
|
Animals | 10 | 2020 | 168757 | 0.040 |
Why?
|
Vomiting | 1 | 2020 | 636 | 0.040 |
Why?
|
Exanthema | 1 | 2021 | 501 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2015 | 3701 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15076 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11031 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2018 | 13033 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 712 | 0.030 |
Why?
|
Papillomaviridae | 2 | 2013 | 1119 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2014 | 2924 | 0.030 |
Why?
|
Liver Neoplasms | 2 | 2014 | 4253 | 0.030 |
Why?
|
Esophagoscopy | 1 | 2018 | 390 | 0.030 |
Why?
|
Histiocytic Sarcoma | 1 | 2016 | 44 | 0.030 |
Why?
|
Prognosis | 3 | 2018 | 29063 | 0.030 |
Why?
|
RNA Transport | 1 | 2015 | 48 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5181 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2016 | 223 | 0.030 |
Why?
|
Wnt Proteins | 2 | 2012 | 721 | 0.030 |
Why?
|
Neoadjuvant Therapy | 2 | 2017 | 2728 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2007 | 3617 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 279 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6773 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2016 | 172 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2016 | 261 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2015 | 1861 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2716 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2007 | 2214 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2007 | 2541 | 0.030 |
Why?
|
beta Catenin | 2 | 2012 | 1059 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2020 | 1375 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2015 | 217 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2016 | 684 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1531 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2015 | 367 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1616 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 323 | 0.030 |
Why?
|
Teratoma | 1 | 2016 | 395 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2020 | 1423 | 0.030 |
Why?
|
HeLa Cells | 1 | 2020 | 3128 | 0.030 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2013 | 96 | 0.030 |
Why?
|
DNA Replication Timing | 1 | 2013 | 35 | 0.030 |
Why?
|
Receptor, erbB-2 | 2 | 2013 | 2416 | 0.030 |
Why?
|
Neoplasms, Second Primary | 1 | 2021 | 1061 | 0.030 |
Why?
|
Ribosomal Proteins | 1 | 2015 | 360 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1170 | 0.030 |
Why?
|
Pyrrolidinones | 1 | 2013 | 117 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3206 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 658 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2013 | 318 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2015 | 813 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2013 | 2915 | 0.030 |
Why?
|
Cell Cycle Proteins | 2 | 2014 | 3462 | 0.030 |
Why?
|
Base Composition | 1 | 2012 | 293 | 0.030 |
Why?
|
Cystectomy | 1 | 2017 | 686 | 0.030 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2015 | 436 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2013 | 353 | 0.030 |
Why?
|
CREB-Binding Protein | 1 | 2012 | 151 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 6538 | 0.030 |
Why?
|
F-Box Proteins | 1 | 2013 | 197 | 0.030 |
Why?
|
TCF Transcription Factors | 1 | 2012 | 140 | 0.030 |
Why?
|
Models, Molecular | 2 | 2012 | 5456 | 0.030 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2013 | 337 | 0.030 |
Why?
|
Clone Cells | 1 | 2015 | 1692 | 0.030 |
Why?
|
Transcription, Genetic | 3 | 2012 | 7722 | 0.030 |
Why?
|
Virus Integration | 1 | 2013 | 299 | 0.030 |
Why?
|
Republic of Korea | 1 | 2013 | 539 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6314 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3557 | 0.020 |
Why?
|
Cisplatin | 1 | 2017 | 1662 | 0.020 |
Why?
|
Vietnam | 1 | 2012 | 408 | 0.020 |
Why?
|
CpG Islands | 1 | 2015 | 1172 | 0.020 |
Why?
|
Pyrimidinones | 1 | 2013 | 371 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1373 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2016 | 914 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2019 | 1988 | 0.020 |
Why?
|
Survival Rate | 2 | 2017 | 12788 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Research Design | 2 | 2020 | 5987 | 0.020 |
Why?
|
Adenine | 1 | 2016 | 936 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 648 | 0.020 |
Why?
|
Papillomavirus Infections | 2 | 2013 | 1587 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2013 | 981 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 2 | 2013 | 4554 | 0.020 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 3703 | 0.020 |
Why?
|
Phosphorylation | 2 | 2015 | 8436 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2016 | 804 | 0.020 |
Why?
|
Mexico | 1 | 2012 | 690 | 0.020 |
Why?
|
NF-kappa B | 1 | 2019 | 2499 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 345 | 0.020 |
Why?
|
Gene Library | 1 | 2013 | 1074 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 498 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2012 | 294 | 0.020 |
Why?
|
Sample Size | 1 | 2013 | 845 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4217 | 0.020 |
Why?
|
DEAD-box RNA Helicases | 1 | 2012 | 375 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2386 | 0.020 |
Why?
|
Gene Fusion | 1 | 2012 | 371 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2825 | 0.020 |
Why?
|
Epigenesis, Genetic | 2 | 2013 | 3647 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2013 | 1097 | 0.020 |
Why?
|
Pyridones | 1 | 2013 | 712 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2013 | 15519 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2046 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2010 | 553 | 0.020 |
Why?
|
Melanocytes | 1 | 2012 | 515 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2013 | 1285 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3588 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2886 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1538 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4479 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 635 | 0.020 |
Why?
|
Piperidines | 1 | 2016 | 1602 | 0.020 |
Why?
|
Diethylnitrosamine | 1 | 2007 | 38 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2013 | 5853 | 0.020 |
Why?
|
BRCA2 Protein | 1 | 2012 | 794 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10943 | 0.020 |
Why?
|
Phenotype | 2 | 2015 | 16365 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2012 | 1791 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 783 | 0.020 |
Why?
|
Intestine, Small | 1 | 2013 | 1241 | 0.020 |
Why?
|
Stromal Cells | 1 | 2013 | 1355 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2012 | 1060 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4933 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 859 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2011 | 1526 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1119 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3479 | 0.020 |
Why?
|
Databases, Factual | 1 | 2002 | 7729 | 0.020 |
Why?
|
Protein Conformation | 1 | 2014 | 4011 | 0.020 |
Why?
|
Heterozygote | 1 | 2013 | 2804 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2012 | 1149 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5179 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4445 | 0.020 |
Why?
|
DNA Replication | 1 | 2012 | 1399 | 0.020 |
Why?
|
Smoking | 2 | 2013 | 8987 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15997 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2017 | 63114 | 0.020 |
Why?
|
Exons | 1 | 2011 | 2437 | 0.020 |
Why?
|
Infant | 2 | 2021 | 35136 | 0.020 |
Why?
|
Indoles | 1 | 2013 | 1839 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 3846 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1676 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2012 | 14557 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2013 | 2309 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 41006 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 1827 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4740 | 0.020 |
Why?
|
Artifacts | 1 | 2013 | 1904 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1990 | 0.020 |
Why?
|
Child | 3 | 2021 | 77709 | 0.010 |
Why?
|
Sulfonamides | 1 | 2013 | 1938 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2703 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2015 | 3474 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3505 | 0.010 |
Why?
|
Mitochondria | 1 | 2016 | 3520 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 7023 | 0.010 |
Why?
|
Models, Genetic | 1 | 2013 | 3494 | 0.010 |
Why?
|
Cell Survival | 1 | 2013 | 5882 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2012 | 2866 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 56430 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8642 | 0.010 |
Why?
|
DNA Damage | 1 | 2012 | 2432 | 0.010 |
Why?
|
DNA Methylation | 1 | 2015 | 4286 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8663 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2012 | 3023 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5867 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12354 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2916 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 85781 | 0.010 |
Why?
|
Glioblastoma | 1 | 2015 | 3481 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2019 | 77449 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4665 | 0.010 |
Why?
|
MicroRNAs | 1 | 2015 | 3752 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4462 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6234 | 0.010 |
Why?
|
Chromatin | 1 | 2011 | 2934 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 9959 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9274 | 0.010 |
Why?
|
Base Sequence | 1 | 2008 | 12797 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7880 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11483 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40075 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.010 |
Why?
|
Liver | 1 | 2007 | 7474 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 35421 | 0.010 |
Why?
|
Prospective Studies | 1 | 2012 | 53288 | 0.000 |
Why?
|
United States | 1 | 2013 | 69872 | 0.000 |
Why?
|